ARTICLE | Clinical News
NeuroPhage preclinical data
November 5, 2012 8:00 AM UTC
In an animal model of PD, single doses of NPT001 significantly reduced brain deposits of alpha synuclein (SNCA) and restored normal function to dopamine-producing cells. Additional data will be prese...